Plethysmograph Market Share

  • Report ID: 4878
  • Published Date: Nov 24, 2025
  • Report Format: PDF, PPT

Plethysmograph Market - Regional Analysis

North American Market Insights

North America industry is likely to account for largest revenue share of 35% by 2035. The growth of the market can be attributed majorly to the increasing awareness of the importance of preventive healthcare, and rising incidences of lung diseases such as asthma. According to the Asthma and Allergy Foundation of America, in the U.S., nearly 26 million people suffer from asthma and nearly 21 million Americans ages 18 and older suffer from asthma. In 2020, approximately 52.9% of children under the age of 5 suffering from asthma had an asthma attack. Asthma is a chronic lung disease that causes breathing difficulties and wheezing. The use of a plethysmograph allows doctors to measure the amount of air that a person can breathe in and out, which is helpful in diagnosing and monitoring asthma. In addition, advancements in connected healthcare technologies and the growing adoption of digital health solutions along with increasing demand for remote patient monitoring among regional populations are also driving the growth of the market in North America.

APAC Market Insights

The Asia Pacific plethysmograph market is estimated to be the second largest, registering a share of about ~27% by the end of 2035. The growth of the market can be attributed majorly to the rising demand for ambulatory monitoring systems and the increasing prevalence of obesity as a result of sedentary lifestyles among the regional population. Obesity can contribute to a number of health issues such as cardiovascular diseases and respiratory problems, which in turn increases the demand for medical care and monitoring. Plethysmographs are used to monitor pulmonary function and are therefore in high demand in the Asia Pacific region attributable to the rising number of obese individuals. Additionally, increasing awareness about the advantages of plethysmograph testing and the availability of cost-effective plethysmograph systems in the region are also expected to drive market growth in the region.

Europe Market Insights

Further, the plethysmograph market in Europe, amongst the market in all the other regions, is projected to hold a majority of the share by the end of 2035. The growth of the market can be attributed majorly to the rising awareness about the benefits of the plethysmograph, the growing demand for technologically advanced medical devices, and the increasing demand for non-invasive diagnostic procedures. The growing number of people addicted to liquor and Smoking is also contributing to product demand in the region. Alcohol and smoking damage the lungs, making them more vulnerable to infection and diseases. This increases the need for accurate and reliable diagnostic tools, such as plethysmographs, to detect and diagnose respiratory problems.

Plethysmograph Market Size

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of plethysmograph is estimated at USD 123.59 million.

The global plethysmograph market size was over USD 117.96 million in 2025 and is anticipated to witness a CAGR of around 5.3%, crossing USD 197.71 million revenue by 2035.

By 2035, North America is expected to command nearly 35% share of the Plethysmograph Market over 2026–2035, propelled by growing awareness of preventive healthcare.

Key players in the market include SCIREQ, Vyaire Medical, ACI Medical LLC, BioTekna Srl, D. E. Hokanson Inc., Geratherm Medical AG, medical equipment Europe GmbH, Medizinische Messtechnik GmbH, MGC Diagnostics Corp., Piston Ltd.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos